These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34026384)

  • 21. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
    Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
    Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse cutaneous drug reactions--a clinico-demographic study in a tertiary care teaching hospital of the Kashmir Valley, India.
    Qayoom S; Bisati S; Manzoor S; Sameem F; Khan K
    Arch Iran Med; 2015 Apr; 18(4):228-33. PubMed ID: 25841943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of cutaneous adverse drug reactions in Southwest China: an 11-year retrospective survey on in-patients of a dermatology ward.
    Zhong H; Zhou Z; Wang H; Niu J; Chen W; Song Z; Hao F
    Dermatitis; 2012; 23(2):81-5. PubMed ID: 22653124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs and the skin: A concise review of cutaneous adverse drug reactions.
    Del Pozzo-Magaña BR; Liy-Wong C
    Br J Clin Pharmacol; 2022 Aug; ():. PubMed ID: 35974692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
    Latha S; Choon SE
    Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey.
    Hunziker T; Künzi UP; Braunschweig S; Zehnder D; Hoigné R
    Allergy; 1997 Apr; 52(4):388-93. PubMed ID: 9188919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous adverse reactions in in-patients in a tertiary care hospital.
    Jhaj R; Uppal R; Malhotra S; Bhargava VK
    Indian J Dermatol Venereol Leprol; 1999; 65(1):14-7. PubMed ID: 20885028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Epidemiological and Clinical Analysis of Cutaneous Adverse Drug Reactions Seen in a Tertiary Care Outpatient Clinic in Cairo, Egypt.
    El-Nabarawy EA; Elmasry MF; El Lawindi MI; Tarek YA
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):233-242. PubMed ID: 30390725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical study of cutaneous drug eruptions in 200 patients.
    Patel RM; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(4):430. PubMed ID: 18810845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.
    Sharma VK; Sethuraman G; Kumar B
    J Postgrad Med; 2001; 47(2):95-9. PubMed ID: 11832597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
    Chattopadhyay C; Chakrabarti N
    Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse cutaneous reactions to drugs].
    Suástegui-Rodríguez I; Campos-Jiménez KI; Domínguez-Cherit J; Méndez-Flores S
    Rev Med Inst Mex Seguro Soc; 2018; 56(1):64-70. PubMed ID: 29368897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of Cutaneous Adverse Reactions to Levetiracetam and Human Leukocyte Antigen Typing in North-Indian Patients.
    Ramanujam B; Ihtisham K; Kaur G; Srivastava S; Mehra NK; Khanna N; Singh M; Tripathi M
    J Epilepsy Res; 2016 Dec; 6(2):87-92. PubMed ID: 28101480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous drug reactions in children: a multicentric study.
    Dilek N; Özkol HU; Akbaş A; Kılınç F; Dilek AR; Saral Y; Metin A; Çalka Ö
    Postepy Dermatol Alergol; 2014 Dec; 31(6):368-71. PubMed ID: 25610351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Study of Cutaneous Adverse Drug Reactions and their Association with Autoimmune Diseases at a Tertiary Centre in South-West Rajasthan, India.
    Rana S; Gupta K; Agarwal N; Ahamed ANM
    Indian J Dermatol; 2021; 66(4):445. PubMed ID: 34759420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse cutaneous reactions to thiacetazone for tuberculosis treatment in Tanzania.
    Ipuge YA; Rieder HL; Enarson DA
    Lancet; 1995 Sep; 346(8976):657-60. PubMed ID: 7544858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
    Sharma R; Dogra D; Dogra N
    Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous Adverse Drug Reactions (CADRs)-Statistical Analysis of the Causal Relationship between the Drug, Comorbidities, Cofactors, and the Cutaneous Reaction-A Single-Centered Study.
    Machoń N; Lewandowska J; Zdanowska N; Placek W; Owczarczyk-Saczonek A
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse cutaneous drug reactions in a single quaternary referral hospital.
    Botelho LF; Porro AM; Enokihara MM; Tomimori J
    Int J Dermatol; 2016 Apr; 55(4):e198-203. PubMed ID: 26710962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous adverse drug reactions among people living with human immunodeficiency virus in a tertiary care hospital in Johor, Malaysia.
    Chua KY; Tey KE
    Int J STD AIDS; 2022 Aug; 33(9):812-820. PubMed ID: 35775121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.